Følg
Thao D. V. Le, M.D. Ph.D.
Thao D. V. Le, M.D. Ph.D.
Massachusetts General Brigham
Verificeret mail på mgh.harvard.edu
Titel
Citeret af
Citeret af
År
FGF21 is an exocrine pancreas secretagogue
KC Coate, G Hernandez, CA Thorne, S Sun, TDV Le, K Vale, SA Kliewer, ...
Cell metabolism 25 (2), 472-480, 2017
1312017
Unexpected effects of the MIP‐CreER transgene and tamoxifen on β‐cell growth in C57Bl6/J male mice
BA Carboneau, TDV Le, JC Dunn, M Gannon
Physiological reports 4 (18), e12863, 2016
462016
Cholesteryl ester transfer protein alters liver and plasma triglyceride metabolism through two liver networks in female mice
BT Palmisano, TD Le, L Zhu, YK Lee, JM Stafford
Journal of lipid research 57 (8), 1541-1551, 2016
402016
Fibroblast growth factor-21 is required for weight loss induced by the glucagon-like peptide-1 receptor agonist liraglutide in male mice fed high carbohydrate diets
TDV Le, P Fathi, AB Watters, BJ Ellis, GLK Besing, N Bozadjieva-Kramer, ...
Molecular metabolism 72, 101718, 2023
232023
High fat diet blunts stress-induced hypophagia and activation of Glp1r dorsal lateral septum neurons in male but not in female mice
MB Bales, SW Centanni, JR Luchsinger, P Fathi, JE Biddinger, TDV Le, ...
Molecular Metabolism 64, 101571, 2022
82022
Glucagon-like peptide-1 receptor activation stimulates PKA-mediated phosphorylation of Raptor and this contributes to the weight loss effect of liraglutide
TDV Le, D Liu, GLK Besing, R Raghavan, BJ Ellis, RP Ceddia, S Collins, ...
Elife 12, e80944, 2023
52023
Effect of a Co-located Bridging Recovery Initiative on Hospital length of stay among patients with opioid use disorder: the BRIDGE Randomized Clinical Trial
D Marcovitz, ML Dear, R Donald, DA Edwards, KA Kast, TDV Le, ...
JAMA Network Open 7 (2), e2356430-e2356430, 2024
32024
Impact of inpatient addiction psychiatry consultation on opioid use disorder outcomes
KA Kast, TDV Le, LS Stewart, AD Wiese, IA Reddy, J Smith, DE Marcovitz, ...
The American Journal on Addictions 33 (5), 543-550, 2024
22024
The Glucagon-Like Peptide 1 Receptor Agonist Liraglutide Stimulates Mechanistic Target of Rapamycin (mTOR) Signaling via PKA And Akt
TDV Le, D Liu, S Collins, JE Ayala
Journal of the Endocrine Society 5 (Supplement_1), A510-A511, 2021
22021
DEVELOPING AN ALGORITHM TO IDENTIFY ALCOHOL USE DISORDER IN THE ELECTRONIC HEALTH RECORDS
M Niarchou, A Jeffery, D Negesse, K Villalovos, T Le, J Raffoul, ...
European Neuropsychopharmacology 75, S9, 2023
2023
The Role of PKA-mTOR Signaling in Mediating Weight Loss and Glucose Tolerance Induced by Liraglutide
T Le, D Liu
Obesity 29, 181-181, 2021
2021
Liver FGF21 Contributes to the Weight Lowering Effects of Liraglutide
TDV Le, JE Ayala
Obesity 28 (S2), 120, 2020
2020
Mechanical Characterization of Photo-crosslinked, Thermoresponsive Hydrogel Thin Films via AFM Nanoindentation
T Le, K Aidala, R Hayward
APS March Meeting Abstracts 2014, D21. 002, 2014
2014
Systemet kan ikke foretage handlingen nu. Prøv igen senere.
Artikler 1–13